"Since 1981, The aim of Arthritis and Rheumatic Disease Specialties is to be known as the center of excellence for the treatment of all forms of arthritis and rheumatic diseases in South Florida as well as the United States. More than thousands of patients served at our state-of-art facility with the best services."

During the past decade, Arthritis and Rheumatic Disease Specialties conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 23 clinical trials were completed, i.e. on average, 76.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 13 clinical trials were completed. i.e. 118.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis and Rheumatic Disease Specialties" #1 sponsor was "Pfizer" with 7 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Human Genome Sciences Inc." with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis and Rheumatic Disease Specialties" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Affibody" with 1 trials as a collaborator, "Amarex Clinical Research" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis and Rheumatic Disease Specialties" are "Rheumatoid Arthritis" (20 trials), "Systemic Lupus Erythematosus" (6 trials), "Lupus Erythematosus, Systemic" (5 trials), "Arthritis, Rheumatoid" (3 trials) and "Gout" (2 trials). Many other conditions were trialed in "Arthritis and Rheumatic Disease Specialties" in a lesser frequency.

Most popular intervention types in "Arthritis and Rheumatic Disease Specialties" are "Drug" (45 trials), "Biological" (9 trials), "Other" (6 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Belimumab 1 mg/kg" (3 trials), "Belimumab 10 mg/kg" (3 trials), "Methotrexate" (3 trials) and "Abatacept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis and Rheumatic Disease Specialties" are 53 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis and Rheumatic Disease Specialties". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Arthritis and Rheumatic Disease Specialties, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis and Rheumatic Disease Specialties, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".